We are live on ! Find out more
PCM

Palisade Capital Management Portfolio holdings

AUM $3B
1-Year Est. Return 14%
This Fund
S&P 500
This Quarter Est. Return
-4.61%
1 Year Est. Return
+14%
3 Year Est. Return
+46.63%
5 Year Est. Return
+57.43%
10 Year Est. Return
+264.35%
AUM
$3.48B
AUM Growth
-$262M
Cap. Flow
-$366M
Cap. Flow %
-10.52%
Top 10 Hldgs %
14.72%
Holding
386
New
13
Increased
89
Reduced
91
Closed
15

Top Sells

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$15.1M
2
GPI icon
Group 1 Automotive
GPI
+$13.9M
3
LRN icon
Stride
LRN
+$11.5M
4
VERX icon
Vertex
VERX
+$7.79M
5
GD icon
General Dynamics
GD
+$7.52M

Sector Composition

Rank Sector Weight
1 Technology 19.99%
2 Financials 15.84%
3 Industrials 12.84%
4 Healthcare 11.16%
5 Consumer Discretionary 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBRA icon
126
Zebra Technologies
ZBRA
$17.8B
$6.56M 0.19%
23,221
+429
+2% +$147K
DH icon
127
Definitive Healthcare
DH
$75.3M
$6.55M 0.19%
2,265,198
+29,774
+1% +$121K
QCOM icon
128
Qualcomm
QCOM
$176B
$6.45M 0.19%
42,020
ATKR icon
129
Atkore
ATKR
$3.16B
$6.42M 0.18%
107,037
+687
+0.6% +$49.1K
NOC icon
130
Northrop Grumman
NOC
$81.2B
$6.07M 0.17%
11,850
CVX icon
131
Chevron
CVX
$366B
$5.96M 0.17%
35,641
-1,019
-3% -$160K
VLTO icon
132
Veralto
VLTO
$24B
$5.93M 0.17%
60,896
-3,440
-5% -$343K
BAC.PRL icon
133
Bank of America Series L
BAC.PRL
$3.99B
$5.65M 0.16%
4,584
-30
-0.7% -$36.8K
EBS icon
134
Emergent Biosolutions
EBS
$248M
$5.55M 0.16%
1,141,589
+202,857
+22% +$1.68M
SHW icon
135
Sherwin-Williams
SHW
$89.8B
$5.37M 0.15%
15,375
-200
-1% -$70.2K
TMO icon
136
Thermo Fisher Scientific
TMO
$220B
$4.91M 0.14%
9,872
+100
+1% +$54.2K
FLYW icon
137
Flywire
FLYW
$2.16B
$4.29M 0.12%
452,012
+242
+0.1% +$3.81K
BOKF icon
138
BOK Financial
BOKF
$8.74B
$4.25M 0.12%
40,852
+1,501
+4% +$161K
BURL icon
139
Burlington
BURL
$23.2B
$4.17M 0.12%
17,481
+407
+2% +$105K
BA.PRA
140
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$8.27B
$4.13M 0.12%
70,000
+30,000
+75% +$1.79M
SSNC icon
141
SS&C Technologies
SSNC
$18.6B
$4M 0.11%
47,834
-10,163
-18% -$841K
RDNT icon
142
RadNet
RDNT
$5.69B
$3.99M 0.11%
+80,178
New +$4.74M
JNJ icon
143
Johnson & Johnson
JNJ
$625B
$3.95M 0.11%
23,798
-1,887
-7% -$295K
ATR icon
144
AptarGroup
ATR
$8.61B
$3.92M 0.11%
26,424
+904
+4% +$136K
DCI icon
145
Donaldson
DCI
$11.4B
$3.75M 0.11%
55,911
+2,243
+4% +$155K
THG icon
146
Hanover Insurance
THG
$7.98B
$3.36M 0.1%
19,310
+694
+4% +$112K
ADBE icon
147
Adobe
ADBE
$105B
$3.32M 0.1%
8,654
SCI icon
148
Service Corp International
SCI
$11.6B
$3.26M 0.09%
40,660
+1,484
+4% +$117K
BRK.A icon
149
Berkshire Hathaway Class A
BRK.A
$1.12T
$3.19M 0.09%
4
ARMK icon
150
Aramark
ARMK
$14.7B
$3.18M 0.09%
92,211
+12,348
+15% +$455K

Similar funds

Palisade Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Palisade Capital Management held 386 positions worth $3.48B, down 7% from $3.75B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Palisade Capital Management withdrew a net $366M in Q1 2025, closing 15 positions and reducing 91 holdings. Its most notable exit was General Dynamics, an estimated $7.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.

Against the trend, Palisade Capital Management opened a new position in Jamf worth $7.57M.

  • Palisade Capital Management's largest Q1 2025 buy was Jamf: 622,783 shares worth $7.57M.
  • Palisade Capital Management added most to SM Energy in Q1 2025, an estimated $13.8M increase.
  • Palisade Capital Management's biggest Q1 2025 reduction was Semtech, cutting an estimated $15.1M.
  • Palisade Capital Management fully exited General Dynamics in Q1 2025, selling an estimated $7.52M.
  • Palisade Capital Management's ten largest holdings make up 15% of its $3.48B portfolio in Q1 2025.
  • Palisade Capital Management opened 13 new positions and closed 15 in Q1 2025.
  • Palisade Capital Management's portfolio value fell 7% quarter-over-quarter to $3.48B.

Based on Palisade Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.